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Abstract
Scorpions are distributed throughout Iran and the genus Hemiscorpius is particularly important in this region. Hemiscorpius
lepturus is the most significant species within the genus in the country. Since scorpionism provoked by Hemiscorpius
comprises a medical emergency, the present study is focused on this important issue. In order to perform the present
work, a review of the medical and health-related literature was carried out in several databases. The current findings
indicate that six species of Hemiscorpius are found in 15 states of Iran, mainly in the south and southwest. Deaths caused
by stings were reported only for two species. The morphological characteristics and geographical distribution of
H. lepturus in Iran, its venom and the toxic compounds, epidemiologic data and clinical manifestations of envenomation
as well as treatment for affected people are herein reviewed and described. H. lepturus venom toxicity differs from other
Iranian scorpions regarding duration and severity. Scorpionism is an important public health problem in Iran, especially
in southwest and south regions and in urban areas. It is more prevalent in children and young people. H. lepturus venom
is primarily a cytotoxic agent and has hemolytic, nephrotoxic and to some extent hepatotoxic activity. The use of
polyvalent antivenom to prevent scorpion sting symptoms is recommended. A well-planned health education program
might be useful in preventing scorpionism.
Keywords: Hemiscorpius, Scorpionism, Scorpion venom, Emergency, Epidemiology
Background
Venomous animals are spread throughout the globe and
play an important role in the terms of ecological balance.
Most species of these animals use their venom for
predation or defense. Some animal venoms may be life
threatening for humans whereas nontoxic animals may
bite a human in defense situations [1, 2]. Some venom-
ous animals inject their toxins into their prey through
stingers or other apparatus, whereas others use mouth
annexes such as fangs in snakes or chelicerae in spiders.
In the latter situation, the victim may be affected by
venom and by the animal’s oral flora [3–6]. Annually, 5
to 7 thousand people are bitten by snakes in Iran, and
the average mortality due to snakebite is 7 to 12 people
per year [7, 8]. Although snakes are usually more
fearsome than other venomous animals, scorpions are
more important than other species in Iran.
There is a rich fauna of venomous animals in Iran,
especially concerning scorpions species [9–12]. Deaths
attributable to scorpion stings, which occur in all regions
of the country, are more numerous than those caused by
other venomous animals [13–16]. Iranian scorpions gen-
erally belong to three families: Buthidae, Hemiscorpiidae
and Scorpionidae. Scorpion stings have been reported in
the country for centuries since there are ancient religious
and historical texts indicating their presence [17–19].
About 50,000 cases of scorpion stings are recorded in
Iran annually. Epidemiological studies have showed that
scorpion stings comprise the major type of envenom-
ation in the country, with most cases happening in the
southwest [20]. Clinical and laboratory symptoms of
scorpionism following Hemiscorpius stings are clearly
different from those reported for other medically
important scorpion species [21, 22]. This phenomenon
is observed in countries such as Iran, Iraq, Pakistan,
Saudi Arabia, Oman, Yemen and United Arab Emirates
[23]. Considering the importance of scorpionism by
Hemiscorpius in Iran, the present study was carried out
to investigate various aspects of this phenomenon in
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A review of the medical and health-related literature
was carried out in several databases including: Medline,
Web of Science, Cochrane Library Database, Scopus,
Google Scholar, SID and Iran Medex. Search terms were:
scorpion, medical care, Iran, Hemiscorpius, Hemiscorpius
lepturus, scorpion sting, antivenom, venom, symptom,
epidemiology, clinical study and distribution. The results
included Persian and English language studies from
1978 to 2016. In addition, sources of medicine history of
Iran before and after Islam were accessed in order to
study the history of scorpionism by Hemiscorpius.
The search strategy and review process were performed
according to the aims of the study, with emphasis on stud-
ies conducted in Iran, restricted to the morphological
characteristics and geographical distribution of H. lepturus
in the country, its venom and the toxic compounds,
epidemiologic data and clinical manifestations of
envenomation as well as treatment with antivenom. A
total of 193 studies matched the search terms, and 71 of
them were excluded after initial screening.
Hemiscorpiidae family
The number of species, genera and families of scorpions
in the world have changed substantially in a relatively
short time. By the last two decades, nearly a thousand spe-
cies have been recognized and described globally [24–27].
So far, 2231 species of scorpions divided into 208 genera
and 20 families have been recognized. According to the
latest revision of the classification of scorpions in Iran,
three families of Buthidae (51 species), Scorpionidae (three
species) and Hemiscorpiidae (five species) were reported
from different parts of the country [20].The Buthidae
family is the largest and most abundant scorpion family in
the world. Moreover, members of this family are consid-
ered the most dangerous ones [28–33].
The Hemiscorpiidae family has undergone several
changes and developments during the last two decades.
Because of the similarity between members of this family
and those of Scorpionidae, they used to be considered as
belonging to the same family in the past. Currently, this
family consists of one genus (Hemiscorpius) and 15
species. Up to this moment, six species of this genus
have been described in Iran (Table 1) [30, 34–36].
Hemiscorpius lepturus is a dangerous species that has
been found in Iran, Oman, Iraq, Saudi Arabia, Yemen,
Pakistan and United Arab Emirates [37–40]. This scorpion
has highly cytotoxic venom that can cause scorpionism in
humans and other animals. Some researchers believe that
scorpionism may be related to several species of
Hemiscorpius, not only H. lepturus. Therefore, it is
important to be able to recognize the involved species
after an incident, specially because Hemiscorpius species
are very similar morphologically [41]. There are records of
deaths attributable to H. lepturus and H. acanthocercus.
Geographic distribution of Hemiscorpius genus
The Hemiscorpiidae family is spread throughout six
countries in the Middle East, including Iran, Iraq,
Pakistan, Saudi Arabia, Oman, Yemen and United Arab
Emirates (Fig. 1) [23].
These scorpions are usually find in hot and humid
areas. In Iran, they have been reported in the provinces
of Khuzestan, Semnan, Fars, Kurdistan, Hormozgan,
Sistan and Baluchestan, Isfahan, Bushehr, Kohgiluyeh
and Boyer-Ahmad, Ilam, Chahar Mahal and Bakhtiari,
Lorestan, Hamedan, Kermanshah and Kerman (Fig. 2)
[20, 40, 42–45].
The historical background of scorpinism by Hemiscorpius
in Iran
The history of Hemiscorpius stings in Iran dates back a
long time [46, 47]. One of the first reports of evenoma-
tion by Hemiscorpius in Iran was presented by Avicenna
in The Canon of Medicine, an encyclopedia of medicine
in five books first published in the eleventh century. He
described the effects of venomous animal bites on
humans as well as possible treatments. In addition, mea-
sures to protect humans from envenomation by animals
were described.
The report was based on documents of scorpionism
syndrome patients from Khuzestan. Avicenna wrote: “As
a result of Gadim [the local name of Hemiscorpius spp.
in Khuzestan] sting, the person does not feel any pain
immediately after it. One or two days later, the injured
person experiences problems caused by the sting. After
that, he or she becomes a very depressed person with a
pale face that may be suffering from jaundice. Tongue is
swelling; the sting location is festering; urine is red
colored, which means it is bloody. The patient may be
suffering from constipation. Heart rate increases and the
person faints, which may lead to death. It should be
noted that if there is less pain, a doctor should not frail
or gullible, because Gadim is highly toxic and deceptive”
[48, 49]. In addition to the clinical symptoms of
Hemiscorpius stings, Avicenna also described the mor-
phological characteristics and habitat of this scorpion
species in Khuzestan and Iraq [48, 49].
Table 1 The described species of Hemiscorpius genus in Iran
Genus Species
Hemiscorpius Hemiscorpius acanthocercus (Monod et Lourenço, 2005)
Hemiscorpius enischnochela (Monod et Lourenço, 2005)
Hemiscorpius gaillardi (Vachon, 1974)
Hemiscorpius lepturus (Peters, 1862)
Hemiscorpius persicus (Birula, 1903)
Hemiscorpius kashkayi (Karataş and Gharkheloo 2013)
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Fig. 1 Distribution of Hemiscorpius species in Middle East (image prepared by R. Dehghani, reproduced with permission)
Fig. 2 Distribution of Hemiscorpius species in Iran (image prepared by R. Dehghani, reproduced with permission)
Dehghani et al. Journal of Venomous Animals and Toxins including Tropical Diseases  (2018) 24:8 Page 3 of 10
The Academy of Gondishapur, also known as The
Jondishapur University, was one of the three Sasanian
centers of education and academy of learning in the city
of Gundeshapur, Khuzestan Province, in Iran during late
antiquity. It was considered the most important medical
center of the ancient world during the 6th and 7th
centuries. Since the capital of Iran during the Sassanian
period was Ctesiphon or Mada’in, which was an area
greatly affected by scorpionism by Hemiscorpius, numer-
ous studies were carried out about this medical problem
by researchers of the Academy of Gondishapur [50, 51].
The clinical manifestations of Hemiscorpius envenom-
ation are quite infrequent, because its venom is one of the
only presenting cytotoxic and hemolytic activities. Cur-
rently, the sting of Hemiscorpius species has been reported
in several provinces of Iran, especially Khuzestan and
Hormozgan, with significant clinical symptoms in victims,
particularly children [52–56]. In traditional Iranian medi-
cine, heating the sting site is one of the first measures. In
the region of Rāmhormoz, people usually apply hot sand
or hot stones immediately at the sting site [48, 49].
The Hemiscorpius genus
Hemiscurpius are non-digger scorpions usually the length
of females and males reaches to 5 and 8 cm, respectively
(males have a longer tail). Therefore, they present sexual
dimorphism and their body color is transparent to turbid
yellow. The pedipalps and legs are lighter in color, while
moveable and fixed fingers of pedipalps are reddish
brown. Brown spots can be observed at the end of the
legs. The moving finger of chelicera have two branches
(Fig. 3) [21, 22, 57].
H. lepturus venom is mainly composed of hemotoxins
and cytotoxins [22]. A peptide isolated from H. lepturus
venoms is hemicalcin, a calcium channel blocker that rep-
resents 0.6% of its crude venom. Intracerebroventricular
injection of 300 ng of hemicalcin in mice induces neuro-
toxic symptoms in vivo, followed by death [58]. Hemitoxin
is a potassium channel inhibitor that represents about
0.1% of crude venom [59]. Likewise, heminecrolysin, with
dermonecrotic activity, and hemilipin (phospholipase A2)
inhibited angiogenesis both in vitro and in vivo [60–62].
One of the most abundant components of H. lepturus
venom are the enzymes that play important roles in scor-
pion venoms. Different enzymes including phospholipases,
metalloproteases, hyaluronidases and proteases were
identified by transcriptome analysis in H. Lepturus venom.
The ester bond of phospholipids, the most important
component of the cell membrane is hydrolyzed by
phospholipases. Whole components of H. lepturus venom
were identified by analyzing the venom gland transcrip-
tome of this Iranian scorpion [63].
Scorpionism by Hemiscorpius
Epidemiological data
Scorpion stings are a major public health problem in
south and southwestern Iran. Although scorpion stinga
are reported in all provinces of the country, most cases
occur in the provinces of Khuzestan, Hormozgan, Sistan
and Baluchestan, Bushehr and Ilam [20].
The average incidence of scorpionism was estimated
to be 59.5 cases per 1 hundred thousand inhabitants and
19.5 deaths take place annually in Iran [20]. However,
some studies indicate that the real number of annual
stings is much higher than that one officially reported
[64, 65]. Whereas the province of Mazandaran, in the
northern region, has the lowest rate of cases (near zero),
Khuzestan, in the southwest of Iran, has the highest one,
reaching 541 cases per hundred thousand people [66].
Among the various species of scorpions in Iran, deaths
are usually reported by stings of Androctonus crassicauda,
H. lepturus and H. acanthocercus. The envenomation pro-
voked by H. lepturus stings is significantly different from
that one of the Buthidae family in severity and duration
[21, 67]. The frequency of deaths caused by H. lepturus
(Gadim) is higher [21, 67, 68].
Data collected during 5 years from two hospitals of
the city of Ahvaz (center of Khuzestan) showed that H.
lepturus was responsible for 10 to 15% of all hospital
referred scorpion stings and 92% of all hospitalized
victims of scorpion stings [21, 69].
Although scorpion stings were reported in southern
and southwestern regions of Iran throughout the year,
studies indicated that most stings happened in the warm
Fig. 3 A photographic illustration of males (on the left) and females
(on the right) specimens of Hemiscorpius lepturus. Note the very
short stinger size and longer tail in males (copyright by R. Dehghani,
reproduced with permission)
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months in spring and summer [15, 16, 21, 69–76]. A
positive significant correlation between the frequency of
scorpion stings and the environment temperature as well
as the sunshine duration was reported [73]. However,
the correlation between stings and relative humidity as a
climate factor was negative [77].
Epidemiological analysis indicated that more than 50 to
60% of patients were from urban regions [15, 21, 69, 72,
76, 78]. Some studies conducted on age and sex distribu-
tion of scorpionism by Hemiscorpius indicated that most
patients were female [71, 75, 78]. Other works, neverthe-
less, revealed that men were more at risk of scorpion stings
than women [15, 66, 70, 72, 74]. Contrarily, a few studies
reported that the frequency of recorded scorpion stings in
both genders was nearly similar and there was not any
significant difference between male and female in all age
groups [16, 21, 69, 79]. Another observation was that
women were more stung by scorpions in indoor places,
whereas men were more at risk in the outdoors [77].
According to some findings, children were at greatest
risk of scorpionism by Hemiscorpius. Envenomation is
usually more severe in children and the mortality is
higher among them [78, 80]. Research indicates that
children under 10 years old and young people (aged
between 10 and 20 years) were the first and second age
groups, respectively, more at risk of scorpionism by
Hemiscorpius in Iran [21, 69, 78, 81].
Most scorpion stings affect the lower part of the body
(legs) [21, 71, 72]. However, other sting sites included
the trunk, hands, head and neck [21]. Stings occurred
mainly at night from 7 p.m. to 5 a.m. and in the early
morning from 5 to 12 a.m. [21, 69].
The time interval observed between Gadim stings and
antivenom treatment was less than 6 h for 56.6% of the
cases, 6 to 12 h for 21% of cases, more than 12 h for
11% of cases and the rest of the victims did not received
any antivenom [66]. A single study showed that the
average time interval was less than 4 h for more than
70% of the hospitalized patients [21].
Clinical data
Scorpionism by Hemiscorpius may affect vital organs,
with deadly consequences. The length of hospitalization
of affected patients is greater than the that of patients
stung by any other species in Iran. The delayed effects of
the venom and its retention in the body are the main
reasons for this phenomenon [81, 82].
Local symptoms It has been reported that H. lepturus
stings on the body are not easily recognized because of
their small size (about 1 mm long). In comparison, black
scorpion (A. crassicauda) stings that have about 6 to
8 mm are easily found [14, 81]. Since local pain due to
H. lepturus stings is minimal, patients usually do not
complain and do not seek medical help until the toxicity
has already been established. The initial symptoms only
include a minor itching at the sting site and mild pain.
Therefore, local manifestations 24 h after the sting may be
considered negligible. Buthidae stings, on the other hand,
such as those by Odonthobuthus doriae, are more painful
in the first moments. Symptoms such as local redness,
inflammation, gangrene, necrosis, ecchymosis and blisters
appears about 24 h after H. lepturus stings [83–85].
Consequently, some patients look for medical aid after a
few days, when the sting site is inflamed and painful. Over
time, the venom penetrates the dermis and adjacent
tissues and causes cellulite and severe inflammation. An
intense pain and cellulitis in the sting area may be seen.
The most important consequences of Hemiscorpius stings,
especially in children, are local necrosis, swelling,
erythema and ecchymosis [21, 22, 69, 81, 86].
If the scorpion stinger passes though the epidermis
and reaches capillaries and lymph system, then the
effects of venom will be more severe. In some of these
cases, venom may reach blood and lymph systems,
causing non-uniform ecchymosis patches. The diameter
of this non-uniform ecchymosis is about 25 cm, but
sometimes does not lead to gangrenous cellulitis and
sore. In these patients, systemic symptoms are rare and
ecchymosis after one or 2 weeks, by itself without any
action, will be improved [22, 87, 88]. Gadim scorpion
venom caused skin sore or necrotic areas with
20–25 mm diameter in experimental rats. It was
reported that any systemic problem was not found and
animals remained alive [53, 89]. In children, stings on
the hands and feet lead to severe swelling and inflamma-
tion due to the soft thin tissue of these areas. Stings on
the neck, face and body in children and adult patients
often are followed by more cellulite and swelling and they
may be more dangerous in terms of sting site. After a
while, the surface area of gangrene is cut out and sores ap-
pear through the fatty tissue under the skin [20, 22]. Ex-
tensive wounds only heal with skin grafts. It seems that in
people or laboratory animals that have severe allergic reac-
tions, the venom movement is stopped due to ulcers and
necrosis. This means that the immune system with severe
skin inflammation prevents blood and oxygen from reach-
ing the sting site, except at the injection area [20, 88].
Systemic effects Cardiotoxic effects of H. leptorus en-
venomation in humans have been reported. However,
studies on the envenomation by this scorpion revealed
that there are arrhythmogenic and negative inotropic ef-
fects in animal models [56]. Gadim venom has significant
effects on white blood cells and, therefore, causes ery-
thematous rashes and petechial hemorrhagic into the skin
[90, 91]. Scorpion venoms, especially the one from Gadim,
have also demonstrated hemolytic activity in vitro and it
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has been observed that the larger the amount of venom,
the greater the extension of hemolytic damage [92, 93].
Patients stung by Gadim, especially children, can report
these symptoms, but they are usually mild in adults and
their effects may continue for 2 to 3 weeks without treat-
ment [86, 94]. Among children, Gadim venom provokes a
significant reduction in hematocrit rates [79].
Acute kidney injury (AKI) is frequently observed in
children stung by H. lepturus. It was reported that for
young patients, the delay in receiving medical care may
result in pigmenturia, microangiopathic hemolysis,
anemia, proteinuria and pyuria, which are predictors for
AKI in children. Hemoglobinuria was found in more
than 50% of H. lepturus sting cases. Hemolytic uremic
syndrome after H. lepturus sting has also been reported
[55, 79, 86, 95–99].
Hemoglobinuria, coagulopathy, transfusion and kidney
problems were more observed in patients who had been
admitted to the hospital after 24 h following the sting.
Kidney problems were present only in patients with blood
cell lysis and hemoglobinuria. The rates of hemoglobinuria
were 93.8% in H. lepturus stung children [81]. Delayed hos-
pital admission was recorded in cases of death. Therefore,
clinical manifestations following H. lepturus envenomation
including late renal failure are mainly time-dependent [24,
100]. Death due to H. lepturus envenomation may be
provoked by cardiovascular or renal failure [83].
Overall, general signs such as seizures, distraction, irrit-
ability, restlessness, nausea, vomiting, headache, and pos-
sibly cyanosis have central nervous origin. These symptoms
indicate the severity of envenomed patients. The central
nervous system manifestations are seen mainly among chil-
dren victims. Mental disorders as restlessness, distractibility,
delusions and inappropriate behavior appears and usually
return to normal as the patient improves. However, some
patients, even after recovery, suffer from mental disorders
such as increased aggressiveness, irritability, depression and
emotional imbalance for longer periods [18, 21, 22, 69, 83].
It has been reported that the main clinical signs of H.
lepturus envenomation are similar to those caused by
spider bites of the genus Loxosceles (L. reclusa and L.
intermedia). Loxoscelism is the only proven arachnological
cause of dermonecrosis in the Western Hemisphere,
particularly in the tropical urban regions of South America.
There are many similarities in the toxic manifestations of
the venom from this spider and the venom from H.
lepturus in terms of the dermonecrosis, nephrotoxicity and
direct hemolytic activities. Hemolysis causing loss of
approximately 15% of the blood volume within 72 h [21,
62, 69, 81, 101–112].
Serotherapy with antivenom
Over the last 30 years, the most frequently used approach
in the treatment of scorpionism in Iran is serotherapy with
multivalent antivenom against six common Iranian
scorpions [113]. The multivalent scorpion antivenom is
presented as 5-mL ampoules of a pepsin digested refined
and concentrated preparation, obtained from equine
hyperimmune serum, stored at 2 to 8 °C. This antivenom is
produced by Razi Institute of Vaccine and Serum Produc-
tion in Karaj, Iran. It has specific potency against the
venoms of the six endemic Iranian scorpions (Androctonus
crassicauda, Buthotus saulcyi, Buthotus schach,
Odontobuthus doriae, Mesobuthus eupeus and H. lepturus)
[113].
Currently in Iran, stung patients, including those stung
by H. lepturus, are treated in most clinical centers with
intramuscular injection of available multivalent scorpion
antivenom [93]. It has been reported that more than
95% of scorpion sting patients received the polyvalent
antivenom. Despite the immediate administration of one
or two doses of polyvalent antivenom intramuscularly at
the hospital, in some severe cases, signs and symptoms
have been observed. This may be due to the elapsed
time between sting and treatment or improper dosage
[93]. It is known that the efficacy of antivenom for rever-
sal of cytotoxic manifestations following envenomation
is time-limited. Therefore, using antivenom as early as
possible before the occurrence of cytotoxic effects on
different organs is recommended [114]. The time of
antivenom injection has an important role in the effect-
iveness of antivenom. The epidemiological data and re-
sults of studies on experimental animals showed that the
chance of preventing the occurrence and progress of sys-
temic signs increases significantly when antivenom is ad-
ministrated early. If any systemic signs or symptoms are
observed in victims, it is recommended the intravenous
administration of antivenom [115–117].
Conclusion
The general results of this literature review indicate that
the toxicity of H. lepturus stings differ from other Iran-
ian scorpion stings in relation to duration and severity.
Even the sting of this scorpion is without acute pain.
Scorpionism by Hemiscorpius may related to several spe-
cies, not only H. lepturus. Hence, recognizing the species
involved in an envenomation case is more important.
Hemiscorpius species are morphologically very close to
each other. Misidentification may induce great mistakes
in the final interpretation of results, which can only lead
to more inefficacy in the treatment of disorders caused
by dangerous scorpion species [41, 118].
Clinical symptoms and mortality from scorpion stings
are related to two main factors: the characteristics of the
stung patient (such as age and health condition) and the
characteristics of the scorpion (such as species and
venom potency) [77, 119, 120]. Scorpionism by
Hemiscorpius is an important public health issue in Iran,
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especially in urban areas of the southwest and south re-
gions. It is more prevalent in children and young people,
whereas the mortality is greater in children. Most cases
are recorded in the warm months of spring and summer
at night. The dermal symptoms and systemic manifesta-
tions caused by H. lepturus indicates that venom of this
species is mixture of toxins that is differs from the other
Iranian scorpion species. H. lepturus venom is primarily
a cytotoxic agent and has hemolytic, nephrotoxic and to
some extent hepatotoxic activities.
The use of polyvalent antivenom to prevent different
symptoms in scorpionism is recommended. According
to evidence, the cardiovascular manifestations of stung
patients, who received antivenom as soon as possible,
were mild and the hemoglobinuria and renal failure were
delayed as well [121, 122].
The high incidence of scorpionism by Hemiscorpius in
Iran, especially in Khuzestan, suggests the necessity of
preventive programs for decreasing the incidence of this
phenomenon. One of the main challenges of controlling
scorpionism is promotion of effective participation and
awareness among the population. A well-planned health
education program might be useful in preventing stings.
Promoting health education, mainly among groups who
are more at risk, about preventive measures against
scorpions integrated with environmental measures and
sanitary education of communities should be goal of
control campaigns.
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